Complex Crystal Arthritis

Overview

The Complex Crystal Arthritis course offers a programme full of content for all rheumatology professionals.

Date: 17 January 2020

Venue: BCEC, Birmingham

CPD: 5 credits

The course will provide delegates with an educational update on topics such as gout as well as the chance to exchange best practice with peers through an interactive discussion of challenging real-life clinical cases.

With a programme packed full of speakers who are leaders in their field of rheumatology, this is the perfect setting to learn from the experts and have the opportunity to ask those all-important questions.

Who should attend?

This one-day course is ideally suited to GPs, consultant rheumatologists, trainees and physicians in other specialties.

Objectives:

Awareness of latest evidence informing optimum urate-lowering therapy and learning how to achieve it in clinical practice
How to manage gout in patients with complex comorbidities such as chronic kidney disease, organ transplantation and cardiovascular disease
Awareness of therapeutic options for gout treatment (other than allopurinol) including febuxostat and uricosuric drugs
Understand role of ultrasound and dual-energy CT (DECT) in diagnosis of crystal arthritis, specific imaging features and diagnostic utility
Understand which metabolic conditions predispose to calcium pyrophosphate crystal deposition and which patients should be screened for these
Understand options for pharmacological management of complex calcium pyrophosphate crystal deposition

This course is now fully booked, please register your interest to be added to the waiting list.

Member rates


Level 1 Consultant, allied specialty consultant, clinical academic and Pharma representatives	£195
Level 2 Rheumatology specialty trainee, foundation trainee, GP, non-clinical scientist, research fellow and specialty doctor	£145
Level 3 Health professional, nurse, charity representative, student and retired	£110

Prices do not include VAT, accommodation or travel.

Non-member rates


Level 1 Consultant, allied specialty consultant, clinical academic and Pharma representatives	£295
Level 2 Rheumatology specialty trainee, foundation trainee, GP, non-clinical scientist, research fellow and specialty doctor	£220
Level 3 Health professional, nurse, charity representative, student and retired	£165

Prices do not include VAT, accommodation or travel.

Programme

Friday 17 January

Morning sessions
09.15-14.00

Includes managing gout and uricosuric drugs sessions

Time	Session title	Speakers
09.15-09.45	Refreshments
09.45-10.00	Welcome and introduction	Dr Edward Roddy
10.00-10.30	Evidence-based urate-lowering therapy: what is it and how is it achieved?	Michelle Hui
10.30-11.15	Managing gout in chronic kidney disease and organ transplant recipients	Dr Edward Roddy
11.15-11.45	Refreshments
11.45-12.15	Febuxostat: effectiveness and safety in clinical practice	Dr Philip Riches
12.15-12.45	Uricosuric drugs: when, how and which one?	Dr Edward Roddy
12.45-13.15	Advanced imaging in crystal arthritis	Dr Richard Wakefield
13.15-14.00	Lunch

Afternoon sessions
14.00-16.00

Includes complex cases and panel discussion

Time	Session title	Speakers
14.00-14.30	Metabolic predisposition in calcium pyrophosphate crystal deposition: who to screen, when and for what?	Dr Pascal Richette
14.30-15.00	Pharmacological management of calcium pyrophosphate crystal deposition	Dr Abhishek Abhishek
15.00-16.00	Complex cases and panel discussion	Dr Abhishek Abhishek, Dr Michelle Hui, Dr Pascal Richette & Dr Edward Roddy
16.00	Close

Complex Crystal Arthritis

Overview

The Complex Crystal Arthritis course offers a programme full of content for all rheumatology professionals.

Date: 17 January 2020

Venue: BCEC, Birmingham

CPD: 5 credits

The course will provide delegates with an educational update on topics such as gout as well as the chance to exchange best practice with peers through an interactive discussion of challenging real-life clinical cases.

With a programme packed full of speakers who are leaders in their field of rheumatology, this is the perfect setting to learn from the experts and have the opportunity to ask those all-important questions.

Who should attend?

This one-day course is ideally suited to GPs, consultant rheumatologists, trainees and physicians in other specialties.

Objectives:

Awareness of latest evidence informing optimum urate-lowering therapy and learning how to achieve it in clinical practice

How to manage gout in patients with complex comorbidities such as chronic kidney disease, organ transplantation and cardiovascular disease

Awareness of therapeutic options for gout treatment (other than allopurinol) including febuxostat and uricosuric drugs

Understand role of ultrasound and dual-energy CT (DECT) in diagnosis of crystal arthritis, specific imaging features and diagnostic utility

Understand which metabolic conditions predispose to calcium pyrophosphate crystal deposition and which patients should be screened for these

Understand options for pharmacological management of complex calcium pyrophosphate crystal deposition

This course is now fully booked, please register your interest to be added to the waiting list.

Member rates

Non-member rates

Programme

Friday 17 January

Morning sessions 09.15-14.00

Includes managing gout and uricosuric drugs sessions

Time

Session title

Speakers

09.15-09.45

Refreshments

09.45-10.00

Welcome and introduction

Dr Edward Roddy

10.00-10.30

Evidence-based urate-lowering therapy: what is it and how is it achieved?

Michelle Hui

10.30-11.15

Managing gout in chronic kidney disease and organ transplant recipients

Dr Edward Roddy

11.15-11.45

Refreshments

11.45-12.15

Febuxostat: effectiveness and safety in clinical practice

Dr Philip Riches

12.15-12.45

Uricosuric drugs: when, how and which one?

Dr Edward Roddy

12.45-13.15

Advanced imaging in crystal arthritis

Dr Richard Wakefield

13.15-14.00

Lunch

Afternoon sessions 14.00-16.00

Includes complex cases and panel discussion

Time

Session title

Speakers

14.00-14.30

Metabolic predisposition in calcium pyrophosphate crystal deposition: who to screen, when and for what?

Dr Pascal Richette

14.30-15.00

Pharmacological management of calcium pyrophosphate crystal deposition

Dr Abhishek Abhishek

15.00-16.00

Complex cases and panel discussion

Dr Abhishek Abhishek, Dr Michelle Hui, Dr Pascal Richette & Dr Edward Roddy

16.00

Close

Programme and speakers are subject to change.

Morning sessions
09.15-14.00

Afternoon sessions
14.00-16.00